A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

New RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in ...

Successful high-affinity B cells can proliferate under special conditions that reduce the risk of mutation. Capturing this ...

SEOUL, March 19 (Yonhap) -- South Korea can play a key role in the "100 days mission" for vaccine development for emerging ...

Nucleic Acid Production revenue was $41.9 million for the fourth quarter, representing a 28.8% decrease year-over-year. The revenue decrease was primarily from large GMP orders in 2023 not recurring ...